GL1X · GenesisL1 explorer

MolNFT v1 · #25970 · protein

S954A mutant of the feruloyl esterase module from clostridium thermocellum complexed with syringate

1WB5 · Endo-1,4-beta-xylanase Y: “S954A mutant of the feruloyl esterase module from clostridium thermocellum complexed with syringate”. X-ray diffraction, 2 ligands (SYR, CD), 8 pockets (best druggability 0.45). MolNFT v1 #25970 on…

PDB
1WB5
Type
protein
Length
566 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Endo-1,4-beta-xylanase Y
EC
3.2.1.8
UniProt
P51584
Ligands
SYR, CD
Pockets
8 · best druggability 0.45

Structure

x-ray diffraction · 1 distinct chain · 33% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BEndo-1,4-beta-xylanase Y (EC 3.2.1.8)protein28333% helix, 20% strandP51584

Ligands and binding sites

  • SYR · Syringate · ligand · 2 copies · chains A, B
  • CD · Cadmium ion · metal · 17 copies · chains A, B
  • GOL · Glycerol · additive · 4 copies · chains A, B
  • ACT · Acetate ion · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1750.450.8219empty
2770.400.7817empty
3890.380.7612empty
4790.370.7717empty
5540.370.8018empty

Interfaces

1 interface between chains.

  • A–B · 1048 Ų buried · 24 hydrogen bonds · protein-protein

Compared structures

  • 1WB5 · S954A mutant of the feruloyl esterase module from clostridium thermocellum complexed with… · the same entry in another collection · chain A against A, TM-score 1.00
  • P51584 · AlphaFold monomer V2.0 prediction for endo-1,4-beta-xylanase Y (P51584) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.